Search results
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune· 7 days agoIn the first quarter of the year, Moderna reported $167 million in sales of its only product on the market, its COVID-19 vaccine called Spikevax. The company’s first quarter ...
Decoding Moderna Inc (MRNA): A Strategic SWOT Insight
Guru Focus· 6 days agoOn May 2, 2024, Moderna Inc (MRNA, Financial) filed its 10-Q report, revealing a challenging quarter with a stark decrease in revenue and a shift from profitability to a net ...
Director AFEYAN NOUBAR sale 15,000 shares of Moderna Inc [MRNA] – Knox Daily
Knox Daily· 6 days agoInvestors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Moderna Inc shares valued at $1,624,836 were sold by AFEYAN ...
AstraZeneca pulls its COVID-19 vaccine from the European market
Atlanta Journal-Constitution· 1 day agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine...
Moderna's Options Frenzy: What You Need to Know - Moderna (NASDAQ:MRNA)
Benzinga· 3 days agoLoading... Loading... Deep-pocketed investors have adopted a bullish approach towards Moderna MRNA , and it's something market players shouldn't ignore. Our tracking of public ...
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barrier
Guru Focus· 3 days agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Italy regulator ‘blocks Forno d’Asolo, Sammontana merger’
Just Food via Yahoo Finance· 7 hours agoDistribuzione Moderna said the AGCM was concerned the merger would provide a market share in frozen...
Was COVID vaccine recalled over health danger fears? What we know
Newsweek· 7 hours agoPharmaceutical company AstraZeneca has initiated a global withdrawal of its COVID-19 vaccine just...
AstraZeneca is pulling its COVID-19 vaccine
Quartz· 1 day agoCambridge, U.K.-based pharma giant AstraZeneca said on Wednesday that it is no longer producing or supplying its COVID-19 vaccine, known as Vaxzeveria,...
Forget Nvidia: These 3 Small-Cap Stocks Offer Up to 557% Upside, According to Select Wall Street...
Motley Fool via Yahoo Finance· 10 hours agoHowever, management delayed filing an emergency use authorization (EUA) application in the U.S., and...